This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities.

It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline.

It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs.

Not yet clear

Not yet clear

Not yet clear

Not yet clear

Not yet clear

Not yet clear